New study aims to find safe scabies dose for toddlers
NCT ID NCT05500326
First seen Mar 24, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study looks at how ivermectin, a medicine for scabies, works in children under 5 years old. Researchers want to find the right dose that is both safe and effective for young kids, who are at higher risk for complications. About 120 children in Laos will take part, and the study will measure drug levels in their blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banchieng Health Centre
Kasy District, Vientiane Province, Laos
-
Hinngoon Health Centre
Kasy District, Vientiane Province, Laos
-
Kasy District Hospital
Kasy District, Vientiane Province, Laos
-
Poonglack Health Centre
Kasy District, Vientiane, Laos
-
ThongMeud Health Centre
Kasy District, Vientiane, Laos
Conditions
Explore the condition pages connected to this study.